KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2025)

Elanco Animal Health's Cash from Investing Activities history spans 9 years, with the latest figure at -$64.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 28.89% year-over-year to -$64.0 million; the TTM value through Dec 2025 reached -$279.0 million, down 124.09%, while the annual FY2025 figure was -$279.0 million, 124.09% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$64.0 million at Elanco Animal Health, up from -$101.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.2 billion in Q3 2024 and bottomed at -$441.0 million in Q3 2021.
  • The 5-year median for Cash from Investing Activities is -$40.0 million (2022), against an average of $50000.0.
  • The largest annual shift saw Cash from Investing Activities plummeted 390.0% in 2022 before it skyrocketed 3555.56% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$74.0 million in 2021, then fell by 2.7% to -$76.0 million in 2022, then surged by 53.95% to -$35.0 million in 2023, then tumbled by 157.14% to -$90.0 million in 2024, then grew by 28.89% to -$64.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Cash from Investing Activities are -$64.0 million (Q4 2025), -$101.0 million (Q3 2025), and -$56.0 million (Q2 2025).